IL91778A - A method for reducing the heterogeneity of monoclonal antibodies - Google Patents

A method for reducing the heterogeneity of monoclonal antibodies

Info

Publication number
IL91778A
IL91778A IL9177889A IL9177889A IL91778A IL 91778 A IL91778 A IL 91778A IL 9177889 A IL9177889 A IL 9177889A IL 9177889 A IL9177889 A IL 9177889A IL 91778 A IL91778 A IL 91778A
Authority
IL
Israel
Prior art keywords
antibodies
incubation
heterogeneity
culture
hours
Prior art date
Application number
IL9177889A
Other languages
English (en)
Hebrew (he)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/364,056 external-priority patent/US5126250A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL91778A publication Critical patent/IL91778A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL9177889A 1988-09-28 1989-09-26 A method for reducing the heterogeneity of monoclonal antibodies IL91778A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25078888A 1988-09-28 1988-09-28
US25078688A 1988-09-28 1988-09-28
US25078788A 1988-09-28 1988-09-28
US07/364,056 US5126250A (en) 1988-09-28 1989-06-09 Method for the reduction of heterogeneity of monoclonal antibodies
CA000613379A CA1332367C (en) 1988-09-28 1989-09-26 Method for the reduction of heterogeneity of monoclonal antibodies

Publications (1)

Publication Number Publication Date
IL91778A true IL91778A (en) 1994-10-07

Family

ID=27508376

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9177889A IL91778A (en) 1988-09-28 1989-09-26 A method for reducing the heterogeneity of monoclonal antibodies

Country Status (17)

Country Link
EP (1) EP0361902B1 (da)
JP (1) JP2925181B2 (da)
CN (1) CN1041392A (da)
AR (1) AR242986A1 (da)
AT (1) ATE101876T1 (da)
AU (1) AU615576B2 (da)
BG (1) BG60017B2 (da)
CA (1) CA1332367C (da)
DE (1) DE68913251T2 (da)
DK (1) DK475389A (da)
ES (1) ES2049332T3 (da)
IE (1) IE63562B1 (da)
IL (1) IL91778A (da)
MX (1) MX170441B (da)
NZ (1) NZ230786A (da)
PL (1) PL162260B1 (da)
RO (1) RO105652B1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11046784B2 (en) 2006-03-31 2021-06-29 Chugai Seiyaku Kabushiki Kaisha Methods for controlling blood pharmacokinetics of antibodies
EP1878747A1 (en) 2006-07-11 2008-01-16 greenovation Biotech GmbH Glyco-engineered antibodies
EP2031064A1 (de) * 2007-08-29 2009-03-04 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Steigerung von Proteintitern
ES2687808T3 (es) 2007-09-26 2018-10-29 Chugai Seiyaku Kabushiki Kaisha Región constante de anticuerpo modificado
SI2202245T1 (sl) 2007-09-26 2016-10-28 Chugai Seiyaku Kabushiki Kaisha Postopek modificiranja izoelektrične točke protitelesa preko aminokislinske substitucije v CDR
PL2275443T3 (pl) 2008-04-11 2016-05-31 Chugai Pharmaceutical Co Ltd Cząsteczka wiążąca antygen zdolna do wiązania dwóch lub więcej cząsteczek antygenu w sposób powtarzalny
TWI440469B (zh) * 2008-09-26 2014-06-11 Chugai Pharmaceutical Co Ltd Improved antibody molecules
JP5717624B2 (ja) 2009-03-19 2015-05-13 中外製薬株式会社 抗体定常領域改変体
TWI544077B (zh) 2009-03-19 2016-08-01 Chugai Pharmaceutical Co Ltd Antibody constant region change body
MX365235B (es) 2010-11-30 2019-05-28 Chugai Pharmaceutical Co Ltd Molécula de unión a antígeno capaz de unir repetidamente a la pluralidad de moléculas de antígeno.
AU2011350456B2 (en) * 2010-12-28 2016-05-26 Chugai Seiyaku Kabushiki Kaisha Animal cell culturing method
PT3489254T (pt) 2012-04-30 2022-12-30 Biocon Ltd Proteínas de fusão direcionadas/imunomoduladoras e seus métodos de fabrico
RU2662991C2 (ru) * 2013-03-12 2018-07-31 Биокон Лтд. Слитые иммуномодулирующие белки и способы их получения
JP6442404B2 (ja) 2013-06-11 2018-12-19 国立研究開発法人国立精神・神経医療研究センター 再発寛解型多発性硬化症(rrms)患者の治療予後予測方法、及び新規治療適応判断方法
CA2972393A1 (en) 2015-02-27 2016-09-01 Chugai Seiyaku Kabushiki Kaisha Composition for treating il-6-related diseases
US10697883B2 (en) 2015-05-19 2020-06-30 National Center Of Neurology And Psychiatry Method for determining application of therapy to multiple sclerosis (MS) patient
HUE054420T2 (hu) * 2016-10-17 2021-09-28 Enzene Biosciences Ltd Folyamatos eljárás terápiás fehérje heterogenitásának csökkentésére
US11851486B2 (en) 2017-05-02 2023-12-26 National Center Of Neurology And Psychiatry Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils
JP7235249B2 (ja) 2017-10-20 2023-03-08 学校法人兵庫医科大学 抗il-6受容体抗体を含有する術後の癒着を抑制するための医薬組成物

Also Published As

Publication number Publication date
DE68913251T2 (de) 1994-06-23
AU4234389A (en) 1990-04-05
JP2925181B2 (ja) 1999-07-28
PL162260B1 (pl) 1993-09-30
BG60017B2 (bg) 1993-06-30
CN1041392A (zh) 1990-04-18
ES2049332T3 (es) 1994-04-16
AR242986A1 (es) 1993-06-30
RO105652B1 (ro) 1992-11-30
CA1332367C (en) 1994-10-11
DK475389A (da) 1990-03-29
NZ230786A (en) 1991-11-26
AU615576B2 (en) 1991-10-03
MX170441B (es) 1993-08-23
DE68913251D1 (de) 1994-03-31
EP0361902A3 (en) 1990-08-16
EP0361902A2 (en) 1990-04-04
EP0361902B1 (en) 1994-02-23
JPH02163096A (ja) 1990-06-22
DK475389D0 (da) 1989-09-27
ATE101876T1 (de) 1994-03-15
IE893094L (en) 1990-03-28
IE63562B1 (en) 1995-05-17

Similar Documents

Publication Publication Date Title
US5126250A (en) Method for the reduction of heterogeneity of monoclonal antibodies
EP0361902B1 (en) Method for the reduction of heterogeneity of monoclonal antibodies
RU2252961C2 (ru) Способ получения амидированного пептида
US4954437A (en) Cell encoding recombinant human erythropoietin
EP0732404A1 (en) Novel expression screening vector
WO1986004336A1 (en) Monoclonal antibodies against core proteins of lymphadenopathy-associated-viruses
EP0162034B1 (en) Method of isolating monoclonal antibodies from hybridoma cultures
EP0169239A1 (en) HUMAN ERYTHROPOIETIN cDNA CLONES
KR960013460B1 (ko) 안티-pci 모노클로날 항체
EP0300459A2 (en) Human pancreatic secretory trypsin inhibitor
EP0816504A2 (en) Platelet activating factor acetylhdrolase, and gene thereof
EP0519728A2 (en) Anti-TCF-II monoclonal antibodies and method for the measurement of TCF-II by applying the antibodies
JPH10226700A (ja) Miaの検出のためのイムノアッセイ
JPH09235300A (ja) ヒトtimp−3及び抗ヒトtimp−3モノクローナル抗体並びにその用途
Inagami Purification of renin and prorenin.
Ishizuka et al. Characterization of monoclonal antibodies against human prorenin profragment and identification of active prorenins in plasma
JP4361579B2 (ja) コンドロイチナーゼabcに対するモノクローナル抗体
JP4090486B2 (ja) コンドロイチン硫酸リアーゼiiに対するモノクローナル抗体
EP0559428B1 (en) Novel polypeptides and DNAs encoding them
JPS61221128A (ja) プラスミノ−ゲン活性化因子に対するモノクロ−ナル抗体とその調製方法及び該モノクロ−ナル抗体の使用方法
JP4361578B2 (ja) コンドロイチン硫酸リアーゼiiに対するモノクローナル抗体
AU752369B2 (en) TNF-alpha converting enzyme
JP4090487B2 (ja) コンドロイチナーゼabcに対するモノクローナル抗体
WO2000009739A1 (fr) Anticorps monoclonal agissant contre la trypsine canine
KR19980701550A (ko) 항-트롬보포이에틴 단일클론 항체(anti-tpo monoclonal antibodies)

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees